Xylem (NYSE: XYL) reported Q4 EPS of $1.42, $0.01 better than the analyst estimate of $1.41. Revenue for the quarter came in at $2.4 billion versus the consensus estimate of $2.37 billion.

GUIDANCE:

Xylem sees FY2026 EPS of $5.35-$5.60, versus the consensus of $5.55. Xylem sees FY2026 revenue of $9.1-9.2 billion, versus the consensus of $9.33 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.